If the patient had a repeated dose of insulin or glucose (during the period of assessment the endpoint as the posttreatment hypoglycemia), only the lowest blood glucose before being given the repeated dose would be determined as the posttreatment blood glucose level. The gene discussed is INS; the disease is Hypoglycemia.